ALT

Altimmune, Inc.

Healthcare · Biotechnology

$342.68 sample

-2.18 (-0.63%) 1D

Market cap

$1.33T

Price as of

2026-10-03

Latest filing

8-K · 2026-09-25

Alerts

8

Price$342.68 +23.26% 3M daily closessample

345.43276.80

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 30INSInsider sell: Chief Financial Officer
Sep 25SECForm 144 filed
Sep 17INSInsider sell: EVP, Operations
Sep 08INSInsider sell: EVP, Operations
Sep 03INSInsider sell: EVP, Operations
Aug 26SECForm 144 filed
Aug 19INSInsider sell: Chief Financial Officer
Aug 11SEC10-Q filed

Sign up to see the real ALT record →

Company facts

SEC EDGAR registration

Name: Altimmune, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -60sample, -100 to +100
Reporting currency: USD

Who is positioning in ALT

sample

Insiders: 13 insider transactions over 90 days, net selling, $498.1M
Congress: 4 members traded over 90 days
Institutions · 13F: 9 funds hold $15.4B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$83.6B +15.1% y/y

Q4 2024Q3 2026

Inventory$50.4B +10.2% y/y

Q4 2024Q3 2026

Accounts receivable$38.5B +21.5% y/y

Q4 2024Q3 2026

Total debt$98.0B +11.8% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $625.8B +4.9% 3M
Sample peer B: $1.27T +1.9% 3M
Sample peer C: $769.3B -4.9% 3M
Sample peer D: $629.4B +15.4% 3M
Sample peer E: $246.2B +4.2% 3M